Analystreport

Aridis Pharmaceuticals, Inc. (NASDAQ: ARDS) had its "buy" rating re-affirmed by analysts at HC Wainwright.

Aridis Pharmaceuticals Inc.  (ARDS) 
Last aridis pharmaceuticals inc. earnings: 11/13 04:05 pm Check Earnings Report